Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
A view of the Novo Nordisk logo in the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, on March 8, 2024.
Tom small | Reuters
Actions of Novo Nordisk He went up on Friday after the Danish pharmaceutical giant reported positive results in the early stages of his medication against amicretine obesity, which is administered once a week.
The trial showed an average weight reduction of 22% in obese and overweight patients after 36 weeks.
The shares rose 9.5% for the last time at 11:02 am, London time.
This is a development story. Consult the updates again.
